Ironsight Therapeutics

Biotech firms rarely choose Midtown for their labs. Yet Ironsight Therapeutics occupies two full floors at 136 Madison Ave, just steps from the energy of Madison Square Park. The neighborhood hums with startups and creative agencies, making it an unexpected but fitting home for a company focused on novel drug development.

Those upper levels house teams working on early-stage therapeutic candidates. While the address places them near retail and dining corridors, the work inside remains largely unseen by passersby. Biotechnology in New York often flies under the radar compared to finance or media, despite the city’s growing life sciences sector.

Finding the right space in Manhattan isn’t easy for companies needing lab infrastructure. 136 Madison Ave Fl 4 & 5 offers proximity to academic institutions and investors, a practical consideration for firms navigating complex research timelines. The building itself blends into the streetscape, its significance visible only to those who know what to look for.

For directions or more information, the map can guide you to their location. If questions arise, no phone number is listed—a reminder that not all businesses operate with public-facing contact. Sometimes the most impactful work happens where the public least expects it.